1
|
Sekiguchi M, Sagano N, Kawazoe H, Hiraga Y, Jibiki A, Yokoyama Y, Suzuki S, Nakamura T. Drug repositioning of antipsychotic drugs for cisplatin-induced pica behavior in mice. Pharmazie 2021; 76:484-487. [PMID: 34620275 DOI: 10.1691/ph.2021.1674] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
We aimed to clarify whether various antipsychotics ameliorate cisplatin-induced pica behavior in mice using a drug repositioning approach. Mice were administered cisplatin (12.5 mg/kg, i.p.) with or without olanzapine (1 mg/kg, i.p.), asenapine (4 mg/kg, i.p.), mirtazapine (5 mg/kg, i.p.) or standard three-drug antiemetics (granisetron [0.5 mg/kg, i.p.], fosaprepitant [25 mg/kg, i.p.], and dexamethasone [3 mg/kg, i.p.]). Kaolin, food, and water intake, and spontaneous motor activity on the day before and seven consecutive days after the cisplatin administration were measured using a telemetry system. At the primary endpoint, kaolin intake was significantly higher at day three in the cisplatin group than in the pre-treatment and saline groups ( p < 0.05). Additionally, kaolin intake was not significantly higher in cisplatin with olanzapine, asenapine, and mirtazapine groups for seven days than in the pre-treatment group. At the secondary endpoint, cisplatin decreased the food and water intake, and spontaneous motor activity in a time-dependent manner. Three antipsychotics failed to improve the cisplatin-induced decrease in food and water intake, and spontaneous motor activity. The findings suggest that prophylactic administration of antipsychotics besides olanzapine may improve cisplatin-induced nausea and vomiting in a delayed phase and de-escalate standard 3-drug antiemetics.
Collapse
Affiliation(s)
- M Sekiguchi
- Division of Pharmaceutical Care Sciences, Center for Social Pharmacy and Pharmaceutical Care Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan
| | - N Sagano
- Division of Pharmaceutical Care Sciences, Center for Social Pharmacy and Pharmaceutical Care Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan
| | - H Kawazoe
- Division of Pharmaceutical Care Sciences, Center for Social Pharmacy and Pharmaceutical Care Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan; Division of Pharmaceutical Care Sciences, Keio University Graduate School of Pharmaceutical Sciences, Tokyo, Japan;,
| | - Y Hiraga
- Division of Pharmaceutical Care Sciences, Center for Social Pharmacy and Pharmaceutical Care Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan
| | - A Jibiki
- Division of Pharmaceutical Care Sciences, Center for Social Pharmacy and Pharmaceutical Care Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan
| | - Y Yokoyama
- Division of Pharmaceutical Care Sciences, Center for Social Pharmacy and Pharmaceutical Care Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan; Division of Pharmaceutical Care Sciences, Keio University Graduate School of Pharmaceutical Sciences, Tokyo, Japan
| | - S Suzuki
- Division of Pharmaceutical Care Sciences, Center for Social Pharmacy and Pharmaceutical Care Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan; Division of Pharmaceutical Care Sciences, Keio University Graduate School of Pharmaceutical Sciences, Tokyo, Japan
| | - T Nakamura
- Division of Pharmaceutical Care Sciences, Center for Social Pharmacy and Pharmaceutical Care Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan; Division of Pharmaceutical Care Sciences, Keio University Graduate School of Pharmaceutical Sciences, Tokyo, Japan
| |
Collapse
|
2
|
Ochi A, Sekiguchi M, Tsujimura K, Kinoshita T, Ueno T, Katayama Y. Two Cases of Equine Multinodular Pulmonary Fibrosis in Japan. J Comp Pathol 2019; 170:46-52. [PMID: 31375158 DOI: 10.1016/j.jcpa.2019.05.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2019] [Revised: 04/20/2019] [Accepted: 05/14/2019] [Indexed: 11/28/2022]
Abstract
Equine multinodular pulmonary fibrosis (EMPF) is a recently described form of interstitial pneumonia associated with equine herpesvirus type 5 (EHV-5). This disease has been reported in North and South America, Europe and Oceania but not, to our knowledge, in horses in Japan. We diagnosed EMPF in two Thoroughbred horses in Japan on the basis of gross and histopathological findings. In both cases, significant gross lesions, restricted to the lungs, consisted of numerous firm and coalescing nodules widely distributed throughout the lung. The nodules were <3 cm in diameter and pale white to tan in colour. Microscopically, they showed severe interstitial fibrosis and infiltration of macrophages, neutrophils, lymphocytes and a few eosinophils. The residual alveoli were lined by cuboidal epithelial cells (type II pneumocytes) and filled with many macrophages, which rarely displayed oval eosinophilic to amphophilic intranuclear inclusion bodies. Polymerase chain reaction and sequence analyses identified the glycoprotein H gene of EHV-5, and in-situ hybridization detected EHV-5 in the alveolar macrophages in the lesions. In one case, electron microscopy revealed herpesvirus-like particles and EHV-5 was isolated from pulmonary lesions.
Collapse
Affiliation(s)
- A Ochi
- Equine Research Institute, Japan Racing Association, 1400-4, Shiba, Shimotsuke, Tochigi, Japan
| | - M Sekiguchi
- Chuo Livestock Hygiene Service Office of Chiba Prefecture, 497 Iwatomi-machi, Sakura, Chiba, Japan.
| | - K Tsujimura
- Equine Research Institute, Japan Racing Association, 1400-4, Shiba, Shimotsuke, Tochigi, Japan
| | - T Kinoshita
- Chuo Livestock Hygiene Service Office of Chiba Prefecture, 497 Iwatomi-machi, Sakura, Chiba, Japan
| | - T Ueno
- Equine Research Institute, Japan Racing Association, 1400-4, Shiba, Shimotsuke, Tochigi, Japan
| | - Y Katayama
- Equine Research Institute, Japan Racing Association, 1400-4, Shiba, Shimotsuke, Tochigi, Japan
| |
Collapse
|
3
|
Suzuki K, Yuki S, Nakano S, Kawamoto Y, Nakatsumi H, Hatanaka K, Ando T, Furukawa K, Ishiguro A, Ohta T, Eto K, Nakajima J, Nakamura M, Sogabe S, Kato K, Tateyama M, Kato S, Sekiguchi M, Sakata Y, Komatsu Y. HGCSG1503: A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer: Analysis of GERCOR index. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy431.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
4
|
Shindo Y, Yuki S, Yagisawa M, Kawamoto Y, Tsuji Y, Hatanaka K, Kobayashi Y, Kajiura S, Ishiguro A, Honda T, Dazai M, Eto K, Nakamura M, Koike M, Ota S, Sato A, Kato K, Ueda A, Fukunaga A, Sekiguchi M, Sakata Y, Komatsu Y. HGCSG1503: A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer: Analysis of cases of prior regorafenib. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy151.257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
5
|
Okubo R, Chen C, Sekiguchi M, Hamazaki K, Matsuoka YJ. Mechanisms underlying the effects of n-3 polyunsaturated fatty acids on fear memory processing and their hypothetical effects on fear of cancer recurrence in cancer survivors. Prostaglandins Leukot Essent Fatty Acids 2018; 131:14-23. [PMID: 29628046 DOI: 10.1016/j.plefa.2018.03.006] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/22/2017] [Revised: 03/14/2018] [Accepted: 03/21/2018] [Indexed: 12/26/2022]
Abstract
The relationship of n-3 polyunsaturated fatty acids (PUFAs) and gut microbiota with brain function has been extensively reported. Here, we review how n-3 polyunsaturated fatty acids affect fear memory processing. n-3 PUFAs may improve dysfunctional fear memory processing via immunomodulation/anti-inflammation, increased BDNF, upregulated adult neurogenesis, modulated signal transduction, and microbiota-gut-brain axis normalization. We emphasize how n-3 PUFAs affect this axis and also focus on the hypothetical effects of PUFAs in fear of cancer recurrence (FCR), the primary psychological unmet need of cancer survivors. Its pathophysiology may be similar to that of post-traumatic stress disorder (PTSD), which involves dysfunctional fear memory processing. Due to fewer adverse effects than psychotropic drugs, nutritional interventions involving n-3 PUFAs should be acceptable for physically vulnerable cancer survivors. We are currently studying the relationship of FCR with n-3 PUFAs and gut microbiota in cancer survivors to provide them with a nutritional intervention that protects against FCR.
Collapse
Affiliation(s)
- R Okubo
- Division of Health Care Research, Center for Public Health Science, National Cancer Center Japan, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
| | - C Chen
- RIKEN Brain Science Institute, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - M Sekiguchi
- Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-cho, Kodaira City, Tokyo 187-8551, Japan
| | - K Hamazaki
- Department of Public Health, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama City, Toyama 930-0194, Japan
| | - Y J Matsuoka
- Division of Health Care Research, Center for Public Health Science, National Cancer Center Japan, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
| |
Collapse
|
6
|
Inoue Y, Sekiguchi M. Clinical application of hysteroscopic hydrotubation for unexplained infertility in the mare. Equine Vet J 2017; 50:470-473. [DOI: 10.1111/evj.12781] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2017] [Accepted: 10/29/2017] [Indexed: 11/28/2022]
Affiliation(s)
- Y. Inoue
- Inoue Equine Clinic; Shin-hidaka Hokkaido Japan
| | | |
Collapse
|
7
|
Kitano M, Kitano S, Sekiguchi M, Azuma N, Hashimoto N, Tsunoda S, Matsui K, Sano H. AB0394 Early Effect of Tofacitinib on Osteoclast Regulator in Rheumatoid Arthritis. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.1413] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
8
|
Furukawa T, Matsui K, Kitano M, Kitano S, Yokoyama Y, Sekiguchi M, Azuma N, Sano H. AB0646 The Role of Serum YKL-40 in Systemic Sclerosis (SSC). Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.3073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
9
|
Kubota A, Suguro T, Sekiguchi M, Ikata S, Takeuchi S, Tsuchiya K. AB0060 Histopathological Change Caused by Biological Treatment in Rheumatoid Arthritis Synovial Tissue. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.3173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
10
|
Komoriya Y, Aluwi N, Ono Y, Kishikawa M, Hirano T, Sekiguchi M. Pleasant music increases cardiac autonomic responses both in young adults with autism spectrum disorder and typical development. Auton Neurosci 2015. [DOI: 10.1016/j.autneu.2015.07.090] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
11
|
Sekiguchi M, Fujii T, Kitano M, Matsui K, Hashimoto H, Yokota A, Miki K, Yamamoto A, Fujimoto T, Hidaka T, Shimmyo N, Maeda K, Kuroiwa T, Yoshii I, Murakami K, Ohmura K, Morita S, Kawahito Y, Nishimoto N, Mimori T, Sano H. AB0472 Predicting Factors Associated with Sustained Clinical Remission by Abatacept are Different Between in Younger and Elderly Patients with Biologic-Naïve Rheumatoid Arthritis (Abroad Study). Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.2693] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
12
|
Kitano M, Kitano S, Sekiguchi M, Azuma N, Abe T, Ogita C, Yokoyama Y, Yoshikawa T, Furukawa T, Hino T, Saito A, Nishioka A, Tsunoda S, Hashimoto N, Matsui K, Iwasaki T, Sano H. SAT0158 Comparison of Early Effect on Bone Metabolism in Patients with Active Rheumatoid Arthritis After Tocilizumab or Abatacept Therapy: Results from Propensity Score Analysis. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.3219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
13
|
Kubota A, Sekiguchi M, Namakumura T, Ikata S, Suguro T. SAT0600 Pathological Change Caused by Biological Drugs in Rheumatoid Arthritis Synovial Tissue. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.1588] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
14
|
Krupkova O, Sekiguchi M, Klasen J, Hausmann O, Konno S, Ferguson SJ, Wuertz-Kozak K. Epigallocatechin 3-gallate suppresses interleukin-1β-induced inflammatory responses in intervertebral disc cells in vitro and reduces radiculopathic pain in rats. Eur Cell Mater 2014; 28:372-86. [PMID: 25422948 DOI: 10.22203/ecm.v028a26] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
Intervertebral disc (IVD) disease, which is characterised by age-related changes in the adult disc, is the most common cause of disc failure and low back pain. The purpose of this study was to analyse the potential of the biologically active polyphenol epigallocatechin 3-gallate (EGCG) for the treatment of painful IVD disease by identifying and explaining its anti-inflammatory and anti-catabolic activity. Human IVD cells were isolated from patients undergoing surgery due to degenerative disc disease (n = 34) and cultured in 2D or 3D. An inflammatory response was activated by IL-1β, EGCG was added, and the expression/activity of inflammatory mediators and pathways was measured by qRT-PCR, western blotting, ELISA, immunofluorescence and transcription factor assay. The small molecule inhibitor SB203580 was used to investigate the involvement of the p38 pathway in the observed effects. The analgesic properties of EGCG were analysed by the von Frey filament test in Sprague-Dawley rats (n = 60). EGCG significantly inhibited the expression of pro-inflammatory mediators and matrix metalloproteinases in vitro, as well as radiculopathic pain in vivo, most probably by modulation of the activity of IRAK-1 and its downstream effectors p38, JNK and NF-κB.
Collapse
Affiliation(s)
- O Krupkova
- Institute for Biomechanics (D-HEST), ETH Zurich, Hönggerbergring 64, HPP O13, 8093 Zurich,
| | | | | | | | | | | | | |
Collapse
|
15
|
Shimizu Y, Shimoyama Y, Kawada A, Kusano M, Hosomi Y, Sekiguchi M, Kawata T, Horie T, Ishii Y, Yamada M, Dobashi K, Takise A. Gastrointestinal symptoms in idiopathic pulmonary fibrosis patients treated with pirfenidone and herbal medicine. J BIOL REG HOMEOS AG 2014; 28:433-442. [PMID: 25316130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
Pirfenidone is an antifibrotic agent for patients with pulmonary fibrosis, but this drug has adverse gastrointestinal (GI) effects. The first aim of this study was to assess GI symptoms due to pirfenidone by using a new questionnaire for reflux symptoms and dismotility symptoms. Whether adding herbal medicine of rikkunshi-to improved GI symptoms due to pirfenidone therapy was also investigated. This was a randomized controlled trial performed on 17 IPF patients. The patients were assigned to two groups, and the study period was 8 weeks. The pirfenidone group received pirfenidone therapy for 8 weeks with add-on rikkunshi-to from 4 weeks, while the control group did not receive either of these agents. To assess the effects of RK, plasma levels of acyl-ghrelin and des-acyl-ghrelin, serum KL-6 and surfactant protein-D, and pulmonary function tests were monitored. GI symptoms were most severe during the initial 2 weeks of pirfenidone therapy at a dose of 600 mg/day. Both reflux symptoms and dismotility symptoms deteriorated. Rikkunshi-to improved GI symptoms to the level prior to pirfenidone therapy. Plasma levels of des-acyl-ghrelin and acyl-/des-acyl-ghrelin ratio changed significantly at 8 weeks compared to 2 weeks. GI adverse events due to PFD were most severe in the first 2 weeks of treatment at a dose of 600 mg/day, and both reflux and dismotility symptoms deteriorated, but the drug was well tolerated at 1200 mg/day. Rikkunshi-to contributed to improvement of GI symptoms, but plasma ghrelin levels did not reflect the improvement of GI symptoms.
Collapse
Affiliation(s)
- Y Shimizu
- Department of Respiratory Medicine, Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - Y Shimoyama
- Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
| | - A Kawada
- Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
| | - M Kusano
- Department of Endoscopy and Endoscopic Surgery, Gunma University Hospital Gastroenterology, Maebashi, Gunma, Japan
| | - Y Hosomi
- Clinical laboratory Center, Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - M Sekiguchi
- Clinical laboratory Center, Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - T Kawata
- Department of Respiratory Medicine, Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - T Horie
- Department of Respiratory Medicine, Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| | - Y Ishii
- Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan
| | - M Yamada
- Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
| | - K Dobashi
- Gunma University School of Health Sciences, Maebashi, Gunma, Japan
| | - A Takise
- Department of Respiratory Medicine, Maebashi Red Cross Hospital, Maebashi, Gunma, Japan
| |
Collapse
|
16
|
Iwasaki T, Sekiguchi M, Tsunemi S, Shibasaki S, Kitano S, Sano H. AB0151 Differential Regulation of C-Met Signal to Synovial Cell Functions in Rheumatoid Arthritis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.2551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
17
|
Murakami M, Ito M, Sekiguchi M, Matsui K, Kitano M, Imura Y, Ohmura K, Fujii T, Kuroiwa T, Maeda K, Morita S, Kawahito Y, Mimori T, Sano H, Nishimoto N. SAT0239 T Cell CD80/Cd86 Co-Stimulatory Blockade Effectively Suppresses CD25 (+) in CD4 (+) T Cell Subpopulation but not the ACPA Titers in the Course of 48-Week Treatment of Patients with Rheumatoid Arthritis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.3997] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
18
|
Murakami M, Ito M, Sekiguchi M, Matsui K, Kitano M, Imura Y, Ohmura K, Fujii T, Kuroiwa T, Maeda K, Morita S, Kawahito Y, Mimori T, Sano H, Nishimoto N. AB0439 T Cell CD80/Cd86 Co-Stimulatory Blockade Does not Suppress CD8 (+) Subpopulation in the Course of 48-Week Treatment of Patients with Rheumatoid Arthritis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.4014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
19
|
Sekiguchi M, Iwasaki T, Shibasaki S, Nygren PÅ, Gräslund T, Sano H. AB0134 Affibody Molecules Inhibiting the Interaction between RAS and RAF Suppress the Proliferation and the Production of Inflammatory Mediators by Synovial Cells. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.2553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
20
|
Kubota A, Sekiguchi M, Miyazaki Y, Nakamura T, Tsuge S, Takamatsu R, Suguro T. AB0306 Does Total Elbow Arthroplasty Improve Disease Activity Scores and HAQ in Patients with Rheumatoid Arthritis Treated with Biologics? Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.2916] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
21
|
Azuma N, Katada Y, Kitano S, Sekiguchi M, Kitano M, Nishioka A, Hashimoto N, Matsui K, Iwasaki T, Sano H. FRI0435 Salivary Epidermal Growth Factor (EGF) in SjÖGren's Syndrome: Association between Salivary EGF Levels and the Severity of Intraoral Manifestations. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.1418] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
22
|
Fujii T, Sekiguchi M, Matsui K, Kitano M, Hashimoto M, Ohmura K, Yamamoto A, Nakahara H, Maeda K, Yokota A, Miki K, Shimmyo N, Kuroiwa T, Murakami K, Ozaki Y, Higami K, Yoshii I, Nozaki Y, Ikawa T, Morita S, Kawahito Y, Nishimoto N, Mimori T, Sano H. AB0334 Very high titer of anti-citrullinated protein antibodies is associated with the achievement of clinical remission by abatacept in biologic-naïve patients with rheumatoid arthritis (the abroad study). Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.2656] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
23
|
Sekiguchi M, Tsunemi S, Kitano S, Sano H, Iwasaki T. THU0089 Hepatocyte Growth Factor Receptor (C-MET) Signaling Pathway Regulates Synovial Cell Production of Inflammatory Mediators and Osteoblast Differentiation. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.617] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
24
|
Kitano M, Kitano S, Ishizu M, Furukawa T, Yoshikawa T, Fujita K, Katashima Y, Sato C, Saito A, Nishioka A, Sekiguchi M, Azuma N, Hashimoto N, Tsunoda S, Matsui K, Iwasaki T, Sano H. SAT0119 Effect of Abatacept on Bone Homeostasis and Osteopontin in Rheumatoid Arthritis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.1845] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
25
|
Matsutani T, Li Y, Murakami M, Lee HM, Aoki C, Sekiguchi M, Matsui K, Kitano M, Namiki M, Ohmura K, Murakami K, Fujii T, Kuroiwa T, Shimaoka Y, Nakahara H, Maeda K, Irimajiri S, Funauchi M, Imura Y, Ikawa T, Nanpei A, Azuma T, Sasaki T, Yokota A, Kawahito Y, Mimori T, Sano H, Nishimoto N. FRI0206 Abatacept (CTLA4-IG) suppresses T cell activation and reduces TH17 cells as well as plasma IL-6 in patients with rheumatoid arthritis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.2663] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
26
|
Kubota A, Sekiguchi M, Nakamura T, Miyazaki Y, Suguro T. THU0426 Does Use of Biologic Agent Increase the Incidence of Postoperative Infection? Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.954] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
27
|
Matsutani T, Murakami M, Sekiguchi M, Matsui K, Kitano M, Namiki M, Ohmura K, Imura Y, Fujii T, Kuroiwa T, Nakahara H, Hika S, Maeda K, Nozaki Y, Funauchi M, Murakami K, Ikawa T, Irimajiri S, Nampei A, Azuma T, Sasaki T, Yokota A, Morita S, Kawahito Y, Mimori T, Sano H, Nishimoto N. SAT0101 Abatacept Treatment Suppresses T Cell Activation in Anti-Cyclic Citrullinated Peptide Antibody (ACPA) Positive RA Patients but not in Acpa Negative RA Patients. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.1827] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
28
|
Murakami M, Matsutani T, Sekiguchi M, Matsui K, Kitano M, Namiki M, Ohmura K, Imura Y, Fujii T, Kuroiwa T, Nakahara H, Higa S, Maeda K, Nozaki Y, Funauchi M, Murakami K, Ikawa T, Irimajiri S, Nampei A, Azuma T, Sasaki T, Yokota A, Morita S, Kawahito Y, Mimori T, Sano H, Nishimoto N. SAT0121 Changes in Cytokine Profiles in Rheumatoid Arthritis Patients During Abatacept Treatment. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.1847] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
29
|
Kitano M, Kitano S, Sato C, Nogami M, Morimoto M, Nishioka A, Sekiguchi M, Azuma N, Hashimoto N, Tsunoda S, Matsui K, Iwasaki T, Sano H. AB0557 Effects of tocilizumab on bone homeostasis and DICKKOPF-1 in rheumatoid arthritis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
30
|
Zhang LQ, Song XN, Dai DP, Zhou XY, Gan W, Takagi Y, Hayakawa H, Sekiguchi M, Cai JP. Lowered Nudix type 5 expression leads to cellular senescence in IMR-90 fibroblast cells. Free Radic Res 2013; 47:511-6. [PMID: 23581889 DOI: 10.3109/10715762.2013.795221] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
The molecule 8-oxo-7,8-dihydroguanine (8-oxoGua), an oxidized form of guanine, can pair with adenine or cytosine during nucleic acid synthesis. RNA sequences that contain 8-oxoGua cause translational errors that lead to the synthesis of abnormal proteins. Human Nudix type 5 (NUDT5), a MutT-related protein, catalyzes the hydrolysis of 8-oxoGDP to 8-oxoGMP, thereby preventing the misincorporation of 8-oxoGua into RNA. To investigate the biological roles of NUDT5 in human fibroblast cells, we established cell lines with decreased levels of NUDT5 expression. In NUDT5 knockdown cells, the RNA oxidation levels were significantly higher, the rates of cellular senescence and cell apoptosis were significantly increased, and the cell viability was significantly decreased in comparison with control cells. These results suggested that the NUDT5 protein could play significant roles in the prevention of RNA oxidation and survival in human fibroblast cells.
Collapse
Affiliation(s)
- L- Q Zhang
- The Key Laboratory of Geriatrics, Beijing Hospital and Beijing Institute of Geriatrics, Ministry of Health, Beijing 100730, PR China
| | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Kitagawa A, Fujita T, Goto A, Hattori T, Hamano T, Hojo S, Honma T, Imaseki H, Katagiri K, Muramatsu M, Sakamoto Y, Sekiguchi M, Suda M, Sugiura A, Suya N. Status of ion sources at National Institute of Radiological Sciences. Rev Sci Instrum 2012; 83:02A332. [PMID: 22380179 DOI: 10.1063/1.3670742] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
The National Institute of Radiological Sciences (NIRS) maintains various ion accelerators in order to study the effects of radiation of the human body and medical uses of radiation. Two electrostatic tandem accelerators and three cyclotrons delivered by commercial companies have offered various life science tools; these include proton-induced x-ray emission analysis (PIXE), micro beam irradiation, neutron exposure, and radioisotope tracers and probes. A duoplasmatron, a multicusp ion source, a penning ion source (PIG), and an electron cyclotron resonance ion source (ECRIS) are in operation for these purposes. The Heavy-Ion Medical Accelerator in Chiba (HIMAC) is an accelerator complex for heavy-ion radiotherapy, fully developed by NIRS. HIMAC is utilized not only for daily treatment with the carbon beam but also for fundamental experiments. Several ECRISs and a PIG at HIMAC satisfy various research and clinical requirements.
Collapse
Affiliation(s)
- A Kitagawa
- National Institute of Radiological Sciences (NIRS), 4-9-1 Anagawa, Inage, Chiba 263-8555, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Abstract
OBJECTIVES MicroRNAs (miRNAs) are small functional RNAs that regulate mRNAs for degradation or translational suppression. In the present study, we aimed to reveal functional importance of miRNA-494 (miR-494) in A549 human lung cancer cells. MATERIALS AND METHODS We established A549 cells that constitutively expressed miR-494. Next, we sought to investigate insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) mRNA as an miR-494 target. For this, we constructed a reporter plasmid bearing potential miR-494 binding sequences derived from the 3'-untranslated region (3'-UTR) of IGF2BP1 mRNA in the 3'-UTR of the luciferase gene. RESULTS Through comparison between miR-494 expressing cells and control cells, we revealed that miR-494 suppressed cell proliferation and colony forming activity, and induced senescence. Reporter activity was inhibited by miR-494. In addition, IGF2BP1 mRNA levels were down-regulated in A549 cells that constitutively expressed miR-494. IGF2BP1 has been shown to bind and suppress IGF2 mRNA, and this could be a reason why IGF2BP1 can regulate cell function. Therefore, we analysed IGF2 mRNA levels and revealed that IGF2 was up-regulated in A549 cells that constitutively expressed miR-494. Finally, elevated IGF2 mRNA levels in A549 cells that constitutively expressed miR-494 were suppressed to basal level by an miR-494 inhibitor. CONCLUSIONS Taken together, IGF2BP1 and its downstream target IGF2 could be a crucial axis for miR-494 in regulation of the destiny of A549 cells.
Collapse
Affiliation(s)
- H Ohdaira
- Department of Life Sciences, Meiji University, Kawasaki, Kanagawa, Japan
| | | | | | | |
Collapse
|
33
|
Tsuji Y, Ohata K, Sekiguchi M, Ito T, Chiba H, Gunji T, Yamamichi N, Fujishiro M, Matsuhashi N, Koike K. An effective training system for endoscopic submucosal dissection of gastric neoplasm. Endoscopy 2011; 43:1033-8. [PMID: 22135195 DOI: 10.1055/s-0031-1291383] [Citation(s) in RCA: 50] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
BACKGROUND AND STUDY AIMS A standard training system for endoscopic submucosal dissection (ESD) remains to be established. In this study, we evaluated the validity of our training program for gastric ESD. PATIENTS AND METHODS Four trainees performed gastric ESD for a total of 117 lesions in 107 patients (27 to 30 consecutive lesions per trainee) at a tertiary referral center during 2 years in the training program. Trainees, who already had the fundamental skills and knowledge needed for ESD, each assisted at 40 gastric ESD procedures, then in 20 cases applied post-ESD coagulation (PEC) to gastric mucosal defects; they then began to perform ESD, starting with gastric antral lesions. Treatment outcomes, including mean procedure time, and rates of en bloc resection, en bloc plus R0 resections, complications, and self-completion, were evaluated, for the initial 15 and subsequent 12 to 15 cases. RESULTS Overall rates of en bloc resection and en bloc plus R0 resection were as high as 100 % and 96.6 %, respectively. Regarding complications, seven cases of delayed hemorrhage (6.0 %) and three cases of perforation (2.6 %) occurred; all complications were solved endoscopically. The most frequent reason for operator change was lack of submucosal dissection skill. The self-completion rate was more than 80 % even in the early period, and did not increase for later cases. CONCLUSIONS Our training system enabled novice operators to perform gastric ESD without a decline in clinical outcomes. Key features of this training are prior intensive learning and actual ESD during the learning period under expert supervision.
Collapse
Affiliation(s)
- Y Tsuji
- Department of Gastroenterology, NTT Medical Center Tokyo, Tokyo, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Sakai K, Kurokawa T, Furui Y, Kuronuma Y, Sekiguchi M, Ando J, Inagaki Y, Tang W, Nakata M, Fujita-Yamaguchi Y. Invasion of carcinoma cells into reconstituted type I collagen gels: visual real-time analysis by time-lapse microscopy. Biosci Trends 2011; 5:10-6. [PMID: 21422595 DOI: 10.5582/bst.2011.v5.1.10] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Stromal-epithelial interactions play a critical role in promoting tumorigenesis and invasion. To obtain detailed information on cancer cell behaviors on the stroma and kinetics of cell migration, which cannot be observed by conventionally-used Boyden chamber assays, this study was aimed at analyzing the cell invasion process in vitro using time-lapse microscopic observation. Serum-free conditions and reconstituted type I collagen gels which provided a basal membrane-stroma-like microenvironment were used to first establish a basal condition. Time-lapse microscopic observation for 30 h of cell invasion into the collagen gel revealed kinetic parameters and individualistic behavior of cancer cells. Of breast cancer MDA-MB-231 or MCF-7 cells and colon cancer LS180 or HT29 cells examined, MDA-MB-231 cells most rapidly disappeared from the collagen gel surface under basal conditions. Estrogen-dependent MCF-7 cells disappeared at a rate approximately two times slower than that of MDA-MB-231 cells under serum- and phenol red-free conditions. By the addition of 10 nM β-estradiol to the basal medium, MCF-7 cell invasion was facilitated to a rate similar to that of MDA-MB-231 cells. Microscopic analyses of collagen gel-sections demonstrated that most of the MDA-MB-231 and MCF-7 cells remained within 60 μm from the gel top under basal conditions, which is consistent with the observation obtained using Boyden chambers that no cells could cross the collagen I gel barrier unless 1% fetal calf serum was added to basal conditions. In summary, this study demonstrated future applicability of this method to understand the initial phase of cancer cell invasion processes.
Collapse
Affiliation(s)
- K Sakai
- Department of Applied Biochemistry, Tokai University, Hiratsuka, Kanagawa, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Kunihiro T, Muroya S, Nakamura A, Nonaka C, Sekiguchi M, Wada H. Mass spectra of the low-lying nonet scalar mesons in the lattice QCD. EPJ Web of Conferences 2010. [DOI: 10.1051/epjconf/20100303010] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
36
|
Komori K, Takagi Y, Sanada M, Lim TH, Nakatsu Y, Tsuzuki T, Sekiguchi M, Hidaka M. A novel protein, MAPO1, that functions in apoptosis triggered by O6-methylguanine mispair in DNA. Oncogene 2009; 28:1142-50. [PMID: 19137017 DOI: 10.1038/onc.2008.462] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
O(6)-Methylguanine produced in DNA induces mutation due to its ambiguous base-pairing properties during DNA replication. To suppress such an outcome, organisms possess a mechanism to eliminate cells carrying O(6)-methylguanine by inducing apoptosis that requires the function of mismatch repair proteins. To identify other factors involved in this apoptotic process, we performed retrovirus-mediated gene-trap mutagenesis and isolated a mutant that acquired resistance to a simple alkylating agent, N-methyl-N-nitrosourea (MNU). However, it was still sensitive to methyl methanesulfonate, 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea, etoposide and ultraviolet irradiation. Moreover, the mutant exhibited an increased mutant frequency after exposure to MNU. The gene responsible was identified and designated Mapo1 (O(6)-methylguanine-induced apoptosis 1). When the expression of the gene was inhibited by small interfering RNA, MNU-induced apoptosis was significantly suppressed. In the Mapo1-defective mutant cells treated with MNU, the mitochondrial membrane depolarization and caspase-3 activation were severely suppressed, although phosphorylation of p53, CHK1 and histone H2AX was observed. The orthologs of the Mapo1 gene are present in various organisms from nematode to humans. Both mouse and human MAPO1 proteins expressed in cells localize in the cytoplasm. We therefore propose that MAPO1 may play a role in the signal-transduction pathway of apoptosis induced by O(6)-methylguanine-mispaired lesions.
Collapse
Affiliation(s)
- K Komori
- Department of Molecular Biology, Biomolecular Engineering Research Institute, Suita, Japan
| | | | | | | | | | | | | | | |
Collapse
|
37
|
|
38
|
Arimori T, Tamaoki H, Nakamura T, Ikemizu S, Ishibashi T, Sekiguchi M, Yamagata Y. Structural basis of the substrate recognition and hydrolysis reaction mechanisms of 8-oxo-dGDPase. Acta Crystallogr A 2008. [DOI: 10.1107/s0108767308091198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
39
|
Zhou M, He HJ, Suzuki R, Tanaka O, Sekiguchi M, Yasuoka Y, Kawahara K, Itoh H, Abe H. Expression of ATP sensitive K+ channel subunit Kir6.1 in rat kidney. Eur J Histochem 2007; 51:43-51. [PMID: 17548268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/15/2023] Open
Abstract
ATP-sensitive K+ (K(ATP)) channels in kidney are considered to play roles in regulating membrane potential during the change in intracellular ATP concentration. They are composed of channel subunits (Kir6.1, Kir6.2), which are members of the inwardly rectifying K+ channel family, and sulphonylurea receptors (SUR1, SUR2A and SUR2B), which belong to the ATP-binding cassette superfamily. In the present study, we have investigated the expression and localization of Kir6.1 in rat kidney with Western blot analysis, immunohistochemistry, in situ hybridization histochemistry, and immunoelectron microscopy. Western blot analysis showed that Kir6.1 was expressed in the mitochondria and microsome fractions of rat kidney and very weakly in the membrane fractions. Immunohistochemistry revealed that Kir6.1 was widely distributed in renal tubular epithelial cells, glomerular mesangial cells, and smooth muscles of blood vessels. In immunoelectron microscopy, Kir6.1 is mainly localized in the mitochondria, endoplasmic reticulum (ER), and very weakly in cell membranes. Thus, Kir6.1 is contained in the kidney and may be a candidate of mitochondrial K(ATP) channels.
Collapse
Affiliation(s)
- M Zhou
- Department of Anatomy, Akita University School of Medicine, Hondo 1-1-1, Akita 010-8543, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Mathé G, Amiel JL, Schwarzenberg L, Doré JF, Goldstein P, Sekiguchi M, Bechet JM. CONDITIONING OF IMMUNOLOGICALLY COMPETENT CELLS BY INCUBATION AT 37°C*. Ann N Y Acad Sci 2006. [DOI: 10.1111/j.1749-6632.1966.tb12864.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
41
|
Cohen SS, Sekiguchi M, Stern JL, Barner HD. THE SYNTHESIS OF MESSENGER RNA WITHOUT PROTEIN SYNTHESIS IN NORMAL AND PHAGE-INFECTED THYMINELESS STRAINS OF ESCHERICHIA COLI. Proc Natl Acad Sci U S A 2006; 49:699-707. [PMID: 16591091 PMCID: PMC299957 DOI: 10.1073/pnas.49.5.699] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Affiliation(s)
- S S Cohen
- DEPARTMENT OF BIOCHEMISTRY, UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE, PHILADELPHIA
| | | | | | | |
Collapse
|
42
|
Yamamoto S, Zalipska J, Aliu E, Andringa S, Aoki S, Argyriades J, Asakura K, Ashie R, Berghaus F, Berns H, Bhang H, Blondel A, Borghi S, Bouchez J, Burguet-Castell J, Casper D, Catala J, Cavata C, Cervera A, Chen SM, Cho KO, Choi JH, Dore U, Espinal X, Fechner M, Fernandez E, Fukuda Y, Gomez-Cadenas J, Gran R, Hara T, Hasegawa M, Hasegawa T, Hayashi K, Hayato Y, Helmer RL, Hiraide K, Hosaka J, Ichikawa AK, Iinuma M, Ikeda A, Inagaki T, Ishida T, Ishihara K, Ishii T, Ishitsuka M, Itow Y, Iwashita T, Jang HI, Jeon EJ, Jeong IS, Joo KK, Jover G, Jung CK, Kajita T, Kameda J, Kaneyuki K, Kato I, Kearns E, Kerr D, Kim CO, Khabibullin M, Khotjantsev A, Kielczewska D, Kim JY, Kim SB, Kitching P, Kobayashi K, Kobayashi T, Konaka A, Koshio Y, Kropp W, Kubota J, Kudenko Y, Kuno Y, Kurimoto Y, Kutter T, Learned J, Likhoded S, Lim IT, Loverre PF, Ludovici L, Maesaka H, Mallet J, Mariani C, Matsuno S, Matveev V, McConnel K, McGrew C, Mikheyev S, Minamino A, Mine S, Mineev O, Mitsuda C, Miura M, Moriguchi Y, Morita T, Moriyama S, Nakadaira T, Nakahata M, Nakamura K, Nakano I, Nakaya T, Nakayama S, Namba T, Nambu R, Nawang S, Nishikawa K, Nitta K, Nova F, Novella P, Obayashi Y, Okada A, Okumura K, Oser SM, Oyama Y, Pac MY, Pierre F, Rodriguez A, Saji C, Sakuda M, Sanchez F, Sarrat A, Sasaki T, Sato H, Scholberg K, Schroeter R, Sekiguchi M, Shiozawa M, Shiraishi K, Sitjes G, Smy M, Sobel H, Sorel M, Stone J, Sulak L, Suzuki A, Suzuki Y, Takahashi T, Takenaga Y, Takeuchi Y, Taki K, Takubo Y, Tamura N, Tanaka M, Terri R, T'jampens S, Tornero-Lopez A, Totsuka Y, Ueda S, Vagins M, Whitehead L, Walter CW, Wang W, Wilkes RJ, Yamada S, Yanagisawa C, Yershov N, Yokoyama H, Yokoyama M, Yoo J, Yoshida M. Improved search for nu(mu) --> nu(e) oscillation in a long-baseline accelerator experiment. Phys Rev Lett 2006; 96:181801. [PMID: 16712358 DOI: 10.1103/physrevlett.96.181801] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/02/2006] [Indexed: 05/09/2023]
Abstract
We performed an improved search for nu(mu) --> nu(e) oscillation with the KEK to Kamioka (K2K) long-baseline neutrino oscillation experiment, using the full data sample of 9.2 x 10(19) protons on target. No evidence for a nu(e) appearance signal was found, and we set bounds on the nu(mu) --> nu(e) oscillation parameters. At Deltam(2)=2.8 x 10(-3) eV(2), the best-fit value of the K2Knu(mu) disappearance analysis, we set an upper limit of sin(2)2theta(mue) < 0.13 at a 90% confidence level.
Collapse
Affiliation(s)
- S Yamamoto
- Department of Physics, Kyoto University, Kyoto 606-8502, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Nishifuji K, Ueda Y, Sano A, Kadoya M, Kamei K, Sekiguchi M, Nishimura K, Iwasaki T. Interdigital involvement in a case of primary cutaneous canine histoplasmosis in Japan. ACTA ACUST UNITED AC 2006; 52:478-80. [PMID: 16268961 DOI: 10.1111/j.1439-0442.2005.00763.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
A 5-year-old male Siberian husky bred outdoor in Tokyo had a swollen paw with interdigital granulomatous lesions in the left hindlimb. The dog had no apparent pulmonary or gastrointestinal involvement. Histopathological analysis of the skin lesions demonstrated yeast-like organisms predominantly within macrophages. Sequence analysis of fungal ribosome RNA gene isolated from a paraffin sample revealed a 100% homology with the teleomorph of Histoplasma capsulatum. The present case may support the concept of primary cutaneous canine histoplasmosis as an endemic phenotype recognized in Japan.
Collapse
Affiliation(s)
- K Nishifuji
- Department of Dermatology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo160-8582
| | | | | | | | | | | | | | | |
Collapse
|
44
|
Hasegawa M, Aliu E, Andringa S, Aoki S, Argyriades J, Asakura K, Ashie R, Berns H, Bhang H, Blondel A, Borghi S, Bouchez J, Burguet-Castell J, Casper D, Cavata C, Cervera A, Chen SM, Cho KO, Choi JH, Dore U, Espinal X, Fechner M, Fernandez E, Fukuda Y, Gomez-Cadenas J, Gran R, Hara T, Hasegawa T, Hayashi K, Hayato Y, Helmer RL, Hill J, Hiraide K, Hosaka J, Ichikawa AK, Iinuma M, Ikeda A, Inagaki T, Ishida T, Ishihara K, Ishii T, Ishitsuka M, Itow Y, Iwashita T, Jang HI, Jeon EJ, Jeong IS, Joo KK, Jover G, Jung CK, Kajita T, Kameda J, Kaneyuki K, Kato I, Kearns E, Kerr D, Kim CO, Khabibullin M, Khotjantsev A, Kielczewska D, Kim JY, Kim SB, Kitching P, Kobayashi K, Kobayashi T, Konaka A, Koshio Y, Kropp W, Kubota J, Kudenko Y, Kuno Y, Kutter T, Learned J, Likhoded S, Lim IT, Loverre PF, Ludovici L, Maesaka H, Mallet J, Mariani C, Maruyama T, Matsuno S, Matveev V, Mauger C, McConnel K, McGrew C, Mikheyev S, Minamino A, Mine S, Mineev O, Mitsuda C, Miura M, Moriguchi Y, Morita T, Moriyama S, Nakadaira T, Nakahata M, Nakamura K, Nakano I, Nakaya T, Nakayama S, Namba T, Nambu R, Nawang S, Nishikawa K, Nitta K, Nova F, Novella P, Obayashi Y, Okada A, Okumura K, Oser SM, Oyama Y, Pac MY, Pierre F, Rodriguez A, Saji C, Sakuda M, Sanchez F, Sarrat A, Sasaki T, Sato H, Scholberg K, Schroeter R, Sekiguchi M, Sharkey E, Shiozawa M, Shiraishi K, Sitjes G, Smy M, Sobel H, Stone J, Sulak L, Suzuki A, Suzuki Y, Takahashi T, Takenaga Y, Takeuchi Y, Taki K, Takubo Y, Tamura N, Tanaka M, Terri R, T'jampens S, Tornero-Lopez A, Totsuka Y, Ueda S, Vagins M, Whitehead L, Walter CW, Wang W, Wilkes RJ, Yamada S, Yamamoto S, Yanagisawa C, Yershov N, Yokoyama H, Yokoyama M, Yoo J, Yoshida M, Zalipska J. Search for coherent charged pion production in neutrino-carbon interactions. Phys Rev Lett 2005; 95:252301. [PMID: 16384451 DOI: 10.1103/physrevlett.95.252301] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/04/2005] [Indexed: 05/05/2023]
Abstract
We report the result from a search for charged-current coherent pion production induced by muon neutrinos with a mean energy of 1.3 GeV. The data are collected with a fully active scintillator detector in the K2K long-baseline neutrino oscillation experiment. No evidence for coherent pion production is observed, and an upper limit of is set on the cross section ratio of coherent pion production to the total charged-current interaction at 90% confidence level. This is the first experimental limit for coherent charged pion production in the energy region of a few GeV.
Collapse
Affiliation(s)
- M Hasegawa
- Department of Physics, Kyoto University, Kyoto 606-8502, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Abstract
OBJECTIVES To investigate whether Schumann resonance (SR) affects blood pressure (BP), heart rate (HR), and depression and, if so, whether the putative BP reactivity to SR (BPR-SR) is associated with health-related lifestyle (HLS), disease-related illnesses (DRI), and depression. METHODS A sample of 56 adults in Urausu, Hokkaido, Japan, wore an ambulatory BP monitor, except for the time in the shower, for seven consecutive days. They completed the Geriatric Depression Scale-Short Form and a health survey questionnaire on HLS and DRI. Group mean differences and within-individual differences in systolic (S) and diastolic (D) BP, mean arterial pressure (MAP), double product (DP), and HR were, respectively, compared between normal and enhanced SR days, using Student's t-test. Correlations between BPR-SR and other characteristics (i.e. age, gender, HLS, DRI, subjective health, and depression) were analyzed, using Pearson's product moment correlation. RESULTS AND DISCUSSION Group mean SBP, DBP, MAP, and DP for enhanced SR days were lower than those for normal days (P=0.005-0.036). DRI was negatively associated with BPR-SR in SBP, DBP, MAP, and DP (P=0.003-0.024), suggesting a better health status for those who showed lower BP on enhanced SR days. HLS was negatively associated with BPR-SR in DBP and MAP (P=0.016-0.029). Males showed higher BPR-SR in DBP and MAP than females (P=0.004-0.016). Neither subjective health nor depression was significantly associated with BPR-SR. Future studies based on larger sample sizes are planned to see whether possible health effects can be generalized.
Collapse
Affiliation(s)
- G. Mitsutake
- Division of Neurocardiology and Chronoecology, Tokyo Women’s Medical University, Medical Center East, Tokyo, Japan
| | - K. Otsuka
- Division of Neurocardiology and Chronoecology, Tokyo Women’s Medical University, Medical Center East, Tokyo, Japan
| | - M. Hayakawa
- Department of Electronic Engineering, University of Electro-Communications, Tokyo, Japan
| | - M. Sekiguchi
- Department of Electronic Engineering, University of Electro-Communications, Tokyo, Japan
| | - G. Cornélissen
- Chronobiology Laboratories, University of Minnesota, Minneapolis, MN, USA
| | - F. Halberg
- Chronobiology Laboratories, University of Minnesota, Minneapolis, MN, USA
| |
Collapse
|
46
|
Sekiguchi M. The role of dystrophin in the central nervous system: a mini review. Acta Myol 2005; 24:93-7. [PMID: 16550924] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/07/2023]
Abstract
Dystrophin is a protein responsible for a severe muscle disease Duchenne muscular dystrophy (DMD). This molecule, a huge 427 kDa protein, is also expressed in brain neurons, but its function in the central nervous system (CNS) has been obscure. It is known that some DMD patients have accompanying symptoms of CNS disorders such as the cognitive impairment or psychiatric disorders. The bases of the CNS symptoms are unknown. Addressing the CNS function of dystrophin would make the advance on the interpretation of the CNS symptoms accompanying with DMD. In this short review, previous findings on dystrophin in the CNS are summarized to facilitate studies on the CNS function of this molecule. Following topics are in particular focused, (1) regional and subcellular distribution of dystrophin in the brain and the function in GABAergic synapses, (2) the CNS abnormality in dystrophin-deficient 'mdx' mice.
Collapse
Affiliation(s)
- M Sekiguchi
- Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
| |
Collapse
|
47
|
Aliu E, Andringa S, Aoki S, Argyriades J, Asakura K, Ashie R, Berns H, Bhang H, Blondel A, Borghi S, Bouchez J, Burguet-Castell J, Casper D, Cavata C, Cervera A, Cho KO, Choi JH, Dore U, Espinal X, Fechner M, Fernandez E, Fukuda Y, Gomez-Cadenas J, Gran R, Hara T, Hasegawa M, Hasegawa T, Hayashi K, Hayato Y, Helmer RL, Hill J, Hiraide K, Hosaka J, Ichikawa AK, Iinuma M, Ikeda A, Inagaki T, Ishida T, Ishihara K, Ishii T, Ishitsuka M, Itow Y, Iwashita T, Jang HI, Jeon EJ, Jeong IS, Joo K, Jover G, Jung CK, Kajita T, Kameda J, Kaneyuki K, Kato I, Kearns E, Kerr D, Kim CO, Khabibullin M, Khotjantsev A, Kielczewska D, Kim JY, Kim S, Kitching P, Kobayashi K, Kobayashi T, Konaka A, Koshio Y, Kropp W, Kubota J, Kudenko Y, Kuno Y, Kutter T, Learned J, Likhoded S, Lim IT, Loverre PF, Ludovici L, Maesaka H, Mallet J, Mariani C, Maruyama T, Matsuno S, Matveev V, Mauger C, McConnel K, McGrew C, Mikheyev S, Minamino A, Mine S, Mineev O, Mitsuda C, Miura M, Moriguchi Y, Morita T, Moriyama S, Nakadaira T, Nakahata M, Nakamura K, Nakano I, Nakaya T, Nakayama S, Namba T, Nambu R, Nawang S, Nishikawa K, Nitta K, Nova F, Novella P, Obayashi Y, Okada A, Okumura K, Oser SM, Oyama Y, Pac MY, Pierre F, Rodriguez A, Saji C, Sakuda M, Sanchez F, Sarrat A, Sasaki T, Scholberg K, Schroeter R, Sekiguchi M, Sharkey E, Shiozawa M, Shiraishi K, Sitjes G, Smy M, Sobel H, Stone J, Sulak L, Suzuki A, Suzuki Y, Takahashi T, Takenaga Y, Takeuchi Y, Taki K, Takubo Y, Tamura N, Tanaka M, Terri R, T'Jampens S, Tornero-Lopez A, Totsuka Y, Ueda S, Vagins M, Walter CW, Wang W, Wilkes RJ, Yamada S, Yamamoto S, Yanagisawa C, Yershov N, Yokoyama H, Yokoyama M, Yoo J, Yoshida M, Zalipska J. Evidence for muon neutrino oscillation in an accelerator-based experiment. Phys Rev Lett 2005; 94:081802. [PMID: 15783876 DOI: 10.1103/physrevlett.94.081802] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/09/2004] [Indexed: 05/24/2023]
Abstract
We present results for nu(mu) oscillation in the KEK to Kamioka (K2K) long-baseline neutrino oscillation experiment. K2K uses an accelerator-produced nu(mu) beam with a mean energy of 1.3 GeV directed at the Super-Kamiokande detector. We observed the energy-dependent disappearance of nu(mu), which we presume have oscillated to nu(tau). The probability that we would observe these results if there is no neutrino oscillation is 0.0050% (4.0 sigma).
Collapse
Affiliation(s)
- E Aliu
- Institut de Fisica d'Altes Energies, Universitat Autonoma de Barcelona, E-08193 Bellaterra (Barcelona), Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Seker S, Arakawa K, Sekiguchi M, Ono Y. Biomonitoring of polycyclic aromatic hydrocarbons on hepatocellular carcinoma cell line. Water Sci Technol 2005; 52:219-24. [PMID: 16445191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/06/2023]
Abstract
Polycyclic aromatic hydrocarbons (PAHs) are not easily degradable and exist as persistent contaminants in water environments. In this study we collected surface sediments and water samples from five different ports around Seto Inland Sea during October 2003 to April 2004. Fifteen PAHs were detected by gas chromatography/mass spectrometer (GC-MS). Expression of CYP1A enzymes was measured by a biochemical activation of 7-ethoxy resorufin ortho-deethylase (EROD). Total water PAHs ranged from 2.5 ng/l to 132 ng/l, while sediment PAHs ranged from 296.3 ng/g to 3992.9 ng/g, which indicate low to high level of PAH pollution. Selected isomer ratios (fluoranthene/pyrene to phenanthrene/anthracene and, total molecular weight of 202/total molecular weight 202-278), and detected PAHs suggested that the origin of pollution could mostly be pyrogenic. The highest total sediment PAHs were observed at the Uno Port while the lowest were at the New Okayama Port. EROD activity implied that PAH extracted from sediment samples affected on CYP1A enzymes expression on the human hepatocellular carcinoma cell line in a short exposure time (12 hours). Relatively EROD activity showed good correlation between PAH concentration and CYP1A expression for sediment samples. The highest EROD values were observed for sediment samples at a dose of 5 ppm. In contrast water samples were at the low induction level even under the highest exposure concentration (50 ppm), except in Mizushima Port. Biomonitoring of water environments by EROD activity could be a necessary tool for understanding the effects of PAHs on living organisms at the base of cell defense.
Collapse
Affiliation(s)
- S Seker
- Department of Environmental and Civil Engineering, University of Okayama, 3-1-1 Tsushima-naka, Okayama 700-8530, Japan
| | | | | | | |
Collapse
|
49
|
Hashimoto N, Iwasaki T, Sekiguchi M, Takatsuka H, Okamoto T, Hashimoto T, Sano H. Autologous hematopoietic stem cell transplantation for refractory antiphospholipid syndrome causing myocardial necrosis. Bone Marrow Transplant 2004; 33:863-6. [PMID: 14755313 DOI: 10.1038/sj.bmt.1704432] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Autologous hematopoietic stem cell transplantation (HSCT) is currently being evaluated as a treatment for autoimmune diseases, including systemic lupus erythematosus (SLE), that are associated with a very severe prognosis. We describe a 27-year-old woman with SLE with a 10-year history of refractory antiphospholipid syndrome (APS). She developed progressive myocardial necrosis despite treatment with corticosteroids, cyclophosphamide (CYC), cyclosporine, and immunopheresis. After conditioning with CYC, fludarabine, and antithymocyte globulin, autologous HSCT using CD34(+) selection was performed. After transplantation, the clinical symptoms caused by APS remitted, and the serum anticardiolipin antibody level decreased. Remission has persisted for 21 months after transplantation. Although a longer follow-up is required for the assessment of efficacy, autologous HSCT may cure patients with refractory APS.
Collapse
Affiliation(s)
- N Hashimoto
- Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan
| | | | | | | | | | | | | |
Collapse
|
50
|
Kawabata A, Aoki-Ota M, Sekiguchi M, Momoi Y, Iwaski T. P-66 Disseminated histiocytic sarcoma in a dog receiving long-term immunosuppressive therapy. Vet Dermatol 2004. [DOI: 10.1111/j.1365-3164.2004.00414_66.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|